Deerfield Management as of June 30, 2013
Portfolio Holdings for Deerfield Management
Deerfield Management holds 110 positions in its portfolio as reported in the June 2013 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Cubist Pharmaceuticals | 5.0 | $106M | 2.2M | 48.29 | |
Dendreon Corp note | 4.0 | $85M | 114M | 0.74 | |
Auxilium Pharmaceuticals | 3.8 | $81M | 4.9M | 16.63 | |
Exelixis Inc cnv | 3.1 | $66M | 67M | 0.98 | |
Nuvasive Inc. conv | 2.9 | $61M | 61M | 1.00 | |
Allergan | 2.7 | $57M | 675k | 84.24 | |
NxStage Medical | 2.6 | $56M | 3.9M | 14.28 | |
Pfizer (PFE) | 2.5 | $52M | 1.9M | 28.01 | |
Array BioPharma | 2.3 | $49M | 11M | 4.54 | |
Teva Pharmaceutical Industries (TEVA) | 2.3 | $49M | 1.2M | 39.20 | |
Hologic Inc cnv | 2.2 | $48M | 48M | 1.00 | |
Volcano Corporation note 1.750%12/0 | 2.2 | $46M | 50M | 0.92 | |
AstraZeneca (AZN) | 2.1 | $44M | 928k | 47.30 | |
Keryx Biopharmaceuticals | 2.1 | $44M | 5.9M | 7.47 | |
Optimer Pharmaceuticals | 2.1 | $44M | 3.0M | 14.47 | |
Sagent Pharmaceuticals | 2.1 | $44M | 2.1M | 20.98 | |
Forest Laboratories | 2.0 | $43M | 1.0M | 41.00 | |
Integra Lifesciences Holdings conv bnd | 1.9 | $41M | 42M | 0.98 | |
Antares Pharma | 1.8 | $39M | 9.4M | 4.16 | |
Infinity Pharmaceuticals (INFIQ) | 1.8 | $38M | 2.4M | 16.19 | |
Intermune Inc note 2.500% 9/1 | 1.6 | $34M | 42M | 0.82 | |
Nektar Therapeutics (NKTR) | 1.6 | $34M | 2.9M | 11.55 | |
Cardinal Health (CAH) | 1.6 | $33M | 700k | 47.20 | |
AngioDynamics (ANGO) | 1.4 | $30M | 2.7M | 11.28 | |
Community Health Systems (CYH) | 1.4 | $30M | 636k | 46.88 | |
Air Methods Corporation | 1.4 | $29M | 869k | 33.86 | |
Brookdale Senior Living note | 1.4 | $30M | 25M | 1.18 | |
Tornier Nv | 1.4 | $29M | 1.6M | 17.50 | |
Catamaran | 1.3 | $28M | 580k | 48.77 | |
Universal American | 1.3 | $27M | 3.1M | 8.89 | |
Merck & Co (MRK) | 1.3 | $27M | 575k | 46.45 | |
Flamel Technologies | 1.2 | $27M | 4.3M | 6.14 | |
Abbvie (ABBV) | 1.2 | $26M | 617k | 41.34 | |
St. Jude Medical | 1.1 | $24M | 525k | 45.63 | |
Aetna | 1.1 | $22M | 350k | 63.54 | |
Ariad Pharmaceuticals | 1.0 | $22M | 1.3M | 17.49 | |
Array Biopharma Inc note 3.000% 6/0 | 1.0 | $22M | 23M | 0.95 | |
Alnylam Pharmaceuticals (ALNY) | 1.0 | $22M | 694k | 31.00 | |
HeartWare International | 1.0 | $21M | 225k | 95.11 | |
Molina Healthcare (MOH) | 1.0 | $21M | 570k | 37.18 | |
Cytokinetics | 1.0 | $21M | 1.8M | 11.57 | |
Clovis Oncology | 1.0 | $21M | 306k | 66.98 | |
Accuray Inc Del note 3.750% 8/0 | 1.0 | $20M | 21M | 0.96 | |
XenoPort | 0.9 | $20M | 4.1M | 4.95 | |
Hca Holdings (HCA) | 0.9 | $20M | 553k | 36.06 | |
Arena Pharmaceuticals | 0.9 | $20M | 2.6M | 7.70 | |
ACADIA Pharmaceuticals (ACAD) | 0.9 | $19M | 1.1M | 18.15 | |
Tenet Healthcare Corporation (THC) | 0.9 | $19M | 408k | 46.10 | |
Pharmacyclics | 0.8 | $18M | 227k | 79.47 | |
Humana (HUM) | 0.8 | $16M | 188k | 84.38 | |
BioMarin Pharmaceutical (BMRN) | 0.7 | $14M | 247k | 55.74 | |
Dendreon Corp cnv | 0.6 | $14M | 14M | 0.99 | |
Edwards Lifesciences (EW) | 0.6 | $13M | 200k | 67.20 | |
Achillion Pharmaceuticals | 0.6 | $13M | 1.6M | 8.18 | |
Portola Pharmaceuticals | 0.6 | $13M | 527k | 24.57 | |
Cempra | 0.6 | $13M | 1.6M | 7.77 | |
Pacific Biosciences of California (PACB) | 0.6 | $12M | 4.9M | 2.53 | |
BioDelivery Sciences International | 0.5 | $11M | 2.6M | 4.06 | |
Dendreon Corporation | 0.5 | $10M | 2.5M | 4.12 | |
Integra LifeSciences Holdings (IART) | 0.5 | $9.5M | 258k | 36.63 | |
Seattle Genetics | 0.4 | $9.4M | 300k | 31.46 | |
Rigel Pharmaceuticals | 0.4 | $9.1M | 2.7M | 3.34 | |
DepoMed | 0.4 | $8.5M | 1.5M | 5.62 | |
Allscripts Healthcare Solutions (MDRX) | 0.4 | $8.0M | 619k | 12.94 | |
Cross Country Healthcare (CCRN) | 0.4 | $8.2M | 1.6M | 5.16 | |
Accuray Incorporated (ARAY) | 0.4 | $8.2M | 1.4M | 5.74 | |
Itmn 2 1/2 12/15/17 | 0.4 | $8.0M | 7.5M | 1.07 | |
Liposcience | 0.4 | $7.7M | 1.1M | 6.99 | |
Ovascience | 0.4 | $7.6M | 556k | 13.73 | |
Alphatec Holdings | 0.3 | $7.5M | 3.7M | 2.05 | |
Zogenix | 0.3 | $6.6M | 3.8M | 1.71 | |
Insmed (INSM) | 0.3 | $6.6M | 554k | 11.96 | |
Anthera Pharmaceuticals | 0.3 | $6.4M | 14M | 0.46 | |
Accuray Inc note 3.500% 2/0 | 0.3 | $6.3M | 5.0M | 1.25 | |
AtriCure (ATRC) | 0.3 | $6.0M | 630k | 9.50 | |
Mei Pharma | 0.3 | $5.9M | 822k | 7.13 | |
Alere Inc note 3.000% 5/1 | 0.3 | $5.7M | 5.8M | 0.99 | |
Durata Therapeutics | 0.3 | $5.4M | 753k | 7.20 | |
XOMA CORP Common equity shares | 0.2 | $4.4M | 1.2M | 3.63 | |
Vocera Communications | 0.2 | $4.0M | 274k | 14.70 | |
Tetraphase Pharmaceuticals | 0.2 | $3.9M | 555k | 7.03 | |
Amedisys (AMED) | 0.1 | $2.7M | 233k | 11.60 | |
USD.01 Mannkind Corp sr unsecured | 0.1 | $2.7M | 2.5M | 1.09 | |
LCA-Vision | 0.1 | $2.5M | 831k | 3.02 | |
Merge Healthcare | 0.1 | $2.5M | 689k | 3.60 | |
Elan Corporation | 0.1 | $2.3M | 165k | 14.14 | |
Dyax | 0.1 | $2.4M | 680k | 3.46 | |
Mannkind Corp note 3.750%12/1 | 0.1 | $2.0M | 2.1M | 0.97 | |
Discovery Laboratories | 0.1 | $2.0M | 1.3M | 1.52 | |
Rite Aid Corporation | 0.1 | $2.0M | 700k | 2.86 | |
Gilead Sciences (GILD) | 0.1 | $1.8M | 35k | 51.26 | |
Mast Therapeutics | 0.1 | $1.7M | 3.9M | 0.43 | |
Auxilium Pharmaceuticals note | 0.1 | $1.5M | 1.5M | 0.97 | |
Palatin Technologies | 0.1 | $1.2M | 2.0M | 0.62 | |
Ironwood Pharmaceuticals (IRWD) | 0.1 | $993k | 100k | 9.93 | |
Gentiva Health Services | 0.0 | $775k | 78k | 9.96 | |
Solta Medical | 0.0 | $773k | 339k | 2.28 | |
Bacterin Intl Hldgs | 0.0 | $866k | 1.9M | 0.45 | |
Hologic (HOLX) | 0.0 | $676k | 35k | 19.31 | |
Illumina (ILMN) | 0.0 | $629k | 8.4k | 74.89 | |
Warner Chilcott Plc - | 0.0 | $688k | 35k | 19.92 | |
Questcor Pharmaceuticals | 0.0 | $454k | 10k | 45.40 | |
Myriad Genetics (MYGN) | 0.0 | $505k | 19k | 26.89 | |
LHC | 0.0 | $374k | 19k | 19.59 | |
Endocyte | 0.0 | $364k | 28k | 13.14 | |
Orexigen Therapeutics | 0.0 | $132k | 23k | 5.85 | |
Almost Family | 0.0 | $252k | 13k | 19.09 | |
Spectrum Pharmaceuticals | 0.0 | $237k | 32k | 7.46 | |
Alkermes (ALKS) | 0.0 | $315k | 11k | 28.64 | |
Icad (ICAD) | 0.0 | $233k | 39k | 5.99 |